Effects of High-dose Intravenous Selenium (Selenase®) in Adult Patients Subjected to Elective All-cause Heart Surgery

NCT01141556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

410

Enrollment

OTHER

Sponsor class

Conditions

Heart; Surgery, Heart, Functional Disturbance as Result
Self Efficacy

Interventions

DRUG: Selenase

Sponsor

University Hospital, Basel, Switzerland